Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03807310 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)

Study acronym: NUTRECOVER
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 2026 → Dec 2026
See other at-risk trials from Maastricht University Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Primary completion pushed from Jul 2026 to Dec 2026
    • Study completion pushed from Jul 2026 to Dec 2027
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 11 of 23 entries
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Primary and study completion dates: May 2025 to Jul 2026v8
  3. Primary and study completion dates: May 2023 to May 2025v7
  4. Re-verified, no change to tracked fieldsv6
  5. Eligibility criteria expanded, about 175 words
    • Secondary endpoints: details revised at 1 of 23 entries
    • Study description expanded, about 29 words
    • Study arms: 2 to 3
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date changed from estimate of Feb 2020 to Feb 19, 2020v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 2019 to Feb 2020
    • Study sites: 0 to 1
    v3
  3. Start date: May 2019 to Oct 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall objective is to investigate the efficacy of targeted nutrient supplementation on daily physical activity level as well as generic health status in patients with COPD. Additionally the investigators aim to investigate the relative effect of targeted nutrient supplementation on the recovery after hospitalization for a COPD exacerbation. The secondary objective is to investigate the effect of targeted nutrient supplementation on mental health, physical performance, blood markers, patient related outcomes and gut health. Additionally, a secondary objective is to compare the gut microbiome composition of patients with COPD compared to healthy controls.
Trial Details
NCT Number NCT03807310
Lead Sponsor Maastricht University Medical Center
Collaborators: Nutricia Research
Conditions
(from sponsor)		 Pulmonary Disease, Chronic Obstructive
Related terms Motor Activity, Pulmonary Disease, Chronic Obstructive
Enrollment 166 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov